Pharmacological Studies on (4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-Ethoxycarbonyl-3-Phenylpropyl)amino] Propionyl}-2-Oxolmidazolidine-4-Carboxylic Acid Hydrochloride (TA-6366), a New ACE Inhibitor: I. ACE Inhibitory and Anti-Hypertensive Activities-Reference-Cited by-同舟云学术

Pharmacological Studies on (4S)-1-Methyl-3-{(2S)-2-[N-((1S)-1-Ethoxycarbonyl-3-Phenylpropyl)amino] Propionyl}-2-Oxolmidazolidine-4-Carboxylic Acid Hydrochloride (TA-6366), a New ACE Inhibitor: I. ACE Inhibitory and Anti-Hypertensive Activities

Published:1990 Issue:2 Volume:53 Page:201-210
ISSN:0021-5198
Container-title:Japanese Journal of Pharmacology
language:en
Short-container-title:Japanese Journal of Pharmacology

Author:

KUBO Masami,KATO Jyouji,OCHIAI Takashi,ISHIDA Ryuichi

Publisher

Elsevier BV

Subject

Pharmacology

Reference16 articles.

1. Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives;Hayashi;J. Med. Chem.,1989

2. A new class of converting enzyme inhibitors;Patchett;Nature,1980

3. Design of potent competitive inhibitors of angiotensin converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids;Cushman;Biochemistry,1977

4. Angiotensin I converting enzyme of the kidney cortex;Oshima;Biochim. Biophys. Acta,1974

5. Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme);Yang;J. Pharmacol. Exp. Ther.,1971

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantification of Imidapril in Human Plasma using the LC-MS/MS Method for Bioequivalence and Pharmacokinetic Studies;Current Pharmaceutical Analysis;2016-03-06

2. Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats;Brain Research;2011-11

3. Imidapril;Drugs;2007

4. A Multicentre, 12-Week Study of Imidapril and Candesartan Cilexetil in??Patients with Mild to Moderate Hypertension Using Ambulatory Blood Pressure Monitoring;Clinical Drug Investigation;2007

5. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: The Iberian Multicenter Imidapril study on hypertension (IMISH);Clinical Therapeutics;2006-12